Trial intelligence / Profile preview

Topical lidocaine predictors of response in peripheral nerve damage

2009-016038-29Phase 4Completed

Sponsor
Danish Pain Research Center
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of lidocaine in Neuralgia and peripheral nerve injury (PNI), sponsored by Danish Pain Research Center. Primary endpoints: Predictive role of preserved nociceptors, large afferent fibers, and dynamic mechanical allodynia for response to lidocaine and Pain intensity response. Started Feb 2010; status: completed.

02

Drugs

lidocaine
03

Conditions

Neuralgiaperipheral nerve injury (PNI)

Beyond the preview

Go deeper on 2009-016038-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016038-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call